Company: FLDDW
Filing Date: 2025-07-28
Form Type: S-1/A
Source: 0001213900-25-068264
Chunk: 2

Company: Fold Holdings, Inc.
Filing Date: 2025-07-28
Form: S-1/A
Chunk 2
---
 consists of (i) up to 9,207,287shares of Common Stock that may be issued by us to SZOP Opportunities I, LLC (“SZOP”) pursuant to an Equity Purchase Facility Agreement, dated as of June 16, 2025, by and between us and SZOP (the “Facility”), and (ii) up to 75,000shares of Common Stock issued as compensation to Cohen & Company Securities, LLC (“Cohen”) (such shares, the “Placement Shares”), which acted as the placement agent in connection with the Facility. The actual number of shares of our Common Stock issuable by us in connection with the Facility will vary depending on the then -currentmarket price of the shares of our Common Stock sold to SZOP under the Facility, but will not exceed 9,207,287 unless and until we obtain approval of the issuance of such additional shares of Common Stock by our stockholders in accordance with the applicable stock exchange rules and file an additional registration statement under the Securities Act of 1933, as amended (the “Securities Act”), with the Securities and Exchange Commission. Under the applicable rules of The Nasdaq Stock Market LLC (“Nasdaq”), we may not issue to the Selling Stockholders shares of our Common Stock representing more than 19.99% of the total number of shares of Common Stock outstanding as of the date of the Facility (the “Exchange Cap”), unless we obtain the approval of our stockholders of the issuance of such shares in excess of the Exchange Cap in accordance with the applicable stock exchange rules. See “ Equity Purchase Facility Agreement” for a description of the Facility and “ Selling Stockholders” for additional information. The Company is not selling any securities under this prospectus, and will not receive any of the proceeds from the resale or other disposition of the shares of our Common Stock by the Selling Stockholders; however, we may receive up to $250,000,000 in aggregate gross proceeds from the sale of shares of Common Stock to SZOP under the Facility, subject to the conditions thereof and assuming we register the resale of all of the shares of Common Stock issuable under the Facility. The Company will control the timing and amount of any sales of shares of Common Stock to SZOP. Actual sales of shares of Common Stock under the Facility will depend on a variety of factors to be determined by the Company from time to time, which may include, without limitation, market conditions, the trading price of the Common Stock and determinations by the Company as to the appropriate